Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.
2.

Progress toward the genetic treatment of the beta-thalassemias.

Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I.

Ann N Y Acad Sci. 2005;1054:78-91. Review.

PMID:
16339654
3.

Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.

Sadelain M, Rivella S, Lisowski L, Samakoglu S, Rivière I.

Best Pract Res Clin Haematol. 2004 Sep;17(3):517-34. Review.

PMID:
15498721
4.

Stem cell engineering for the treatment of severe hemoglobinopathies.

Sadelain M, Boulad F, Lisowki L, Moi P, Riviere I.

Curr Mol Med. 2008 Nov;8(7):690-7. Review.

PMID:
18991654
5.
6.

Toward gene therapy for disorders of globin synthesis.

Tisdale J, Sadelain M.

Semin Hematol. 2001 Oct;38(4):382-92. Review.

PMID:
11605174
8.

Gene transfer. A potential approach to gene therapy for sickle cell disease.

Bank A, Markowitz D, Lerner N.

Ann N Y Acad Sci. 1989;565:37-43. Review.

PMID:
2672970
9.
10.

A promising genetic approach to the treatment of beta-thalassemia.

May C, Sadelain M.

Trends Cardiovasc Med. 2001 Oct;11(7):276-80. Review.

PMID:
11709281
11.

Gene therapy for human hemoglobinopathies.

Walsh CE, Liu JM, Miller JL, Nienhuis AW, Samulski RJ.

Proc Soc Exp Biol Med. 1993 Dec;204(3):289-300. Review.

PMID:
8234372
12.

Current status of globin gene therapy for the treatment of beta-thalassaemia.

Lisowski L, Sadelain M.

Br J Haematol. 2008 May;141(3):335-45. doi: 10.1111/j.1365-2141.2008.07098.x. Review.

PMID:
18410569
13.

The beta-globin locus control region versus gene therapy vectors: a struggle for expression.

Ellis J, Pannell D.

Clin Genet. 2001 Jan;59(1):17-24. Review.

PMID:
11168020
14.

Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.

Clay TM, Custer MC, Spiess PJ, Nishimura MI.

Pathol Oncol Res. 1999;5(1):3-15. Review.

15.

Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress.

Emery DW, Stamatoyannopoulos G.

Ann N Y Acad Sci. 1999 Apr 30;872:94-107; discussion 107-8. Review.

PMID:
10372114
16.

Progress toward vector design for hematopoietic stem cell gene therapy.

Hawley RG.

Curr Gene Ther. 2001 May;1(1):1-17. Review.

PMID:
12109133
17.

Retroviral vectors aimed at the gene therapy of human beta-globin gene disorders.

Pawliuk R, Bachelot T, Raftopoulos H, Kalberer C, Humphries RK, Bank A, Leboulch P.

Ann N Y Acad Sci. 1998 Jun 30;850:151-62. Review.

PMID:
9668537
18.

The vagaries of variegating transgenes.

Martin DI, Whitelaw E.

Bioessays. 1996 Nov;18(11):919-23. Review.

PMID:
8939070
19.

Stem cell gene therapy, position effects and chromatin insulators.

Neff T, Shotkoski F, Stamatoyannopoulos G.

Stem Cells. 1997;15 Suppl 1:265-71. Review.

20.

Major challenges for gene therapy of thalassemia and sickle cell disease.

Papanikolaou E, Anagnou NP.

Curr Gene Ther. 2010 Oct;10(5):404-12. Review.

PMID:
20712578

Supplemental Content

Support Center